அறிவியல் ஆவணங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறிவியல் ஆவணங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறிவியல் ஆவணங்கள் Today - Breaking & Trending Today

After reading 14,000 science papers, 200 scientists from 60 countries said – in the next 20 years, the global temperature will increase by 1.5 degrees and the devastation will start. | 200 वैज्ञानिकों ने 14,000 साइंस पेपर्स पढ़ने के बाद कहा- अगले 20 साल में ग्लोबल टेम्परेचर 1.5 डिग्री बढ़ जाएगा और तबाही शुरू हो जाएगी

इसी साल 9 जुलाई को कनाडा में पहली बार पारा 49.6 डिग्री पहुंचा, गर्मी से लोग चलते-चलते सड़कों पर गिरने लगे। इसी दिन अमेरिका के उत्तरी कैलिफोर्निया बॉर्डर में 4 लाख एकड़ से ज्यादा जंगल जल रहे थे। ठीक इसी दिन न्यूजीलैंड में इतनी बर्फ पड़ी कि सड़कें जाम हो गईं। घर से बाहर निकलने पर पाबंदी लगा दी गई। | After reading 14,000 science papers, 200 scientists from 60 countries said – in the next 20 years, the global temperature will increase by 1.5 degrees and the devastation will start. ....

United Kingdom , United States , Andhra Pradesh , New Zealand General , New Zealand , Saudi Arabia , Arabian Sea , India General , Tamil Nadu , Kingdom Of Saudi Arabia , Juna Sept , Janardhan Pandey , Skaimeta Mahesh , Science Papers On Research , United Nations , Science Papers , North California , Heat Wave , James Bay , Country Hungary , West Bengal , East Coast , Afterreading 14 , 000 Science Papers , 00 Scientists From 60 Countries Said In The Next 20 Years , He Global Temperature Will Increase By 1 5 Degrees And The Devastation Start ,

Greek Academics Among Most Influential Scientific Minds Worldwide


Greek Academics Among Most Influential Scientific Minds Worldwide
Credit: Greek Reporter
In a testament to the quality of scientific research and education the country, three Greek academics have recently been ranked among the world’s most influential scientific minds.
A Greek man even topped the list of the most influential academics in the world.
” width=”1080″>
Christodoulos Stefanadis, a Professor of Cardiology at the Medical School of the University of Athens, ranked first on the list with a total of 3,079 publications.
The next Greek in the rankings was Dimosthenis Panagiotakos, a Professor of Biostatistics Research Methods and Epidemiology at Harokopio University in Athens, with 2,432 publications. ....

Christodoulos Stefanadis , Nektarios Benekos , Meletios Athanasios Dimopoulos , Dimosthenis Panagiotakos , Thomson Reuters , School Of The University Athens , University Of Thessaloniki , Professor Of Biostatistics Research Methods , University Of Athens , Harokopio University , Kapodistrian University Of Athens , Aristotle University Of Thessaloniki , University Of Crete , National Kapodistrian University Of Athens , Medical School , Biostatistics Research Methods , National Kapodistrian University , Aristides Tsatsakis , Scientific Papers , World Universities , Kapodistrian University , Aristotle University , தாம்சன் ராய்ட்டர்ஸ் , பள்ளி ஆஃப் தி பல்கலைக்கழகம் ஏதென்ஸ் , பல்கலைக்கழகம் ஆஃப் ஏதென்ஸ் , பல்கலைக்கழகம் ஆஃப் கிரேட் ,

Worldwide Industry for CAR-T Cell Therapy (2021 to 2027) - Players Profiled Include Aleta BioTherapeutics, Anixa Biosciences and BioNTech Among Others


Share this article
Share this article
ResearchAndMarkets.com s offering.
CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as living drugs.
T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune system and play a key role in directing the immune response and killing cells infected by pathogens. In CAR-T cell therapy, blood is drawn from the patient and the T-cells are separated out. In the laboratory, a disarmed virus is then used to genetically engineer the T-cells to produce chimeric antigen receptors (CARs) on their surface. These receptors are synthetic and do not exist naturally. Once infused into the patient, these CARs enable the T-cells to recognize and get a ....

Astellas Adaptimmune , Allogene Maxcyte , Juno Oxford Biomedica , Kymriah Tisagenlecleucel , Attars Biotherapeutics , Cellectis Servier , Oxford Biomedica , Tecartus Brexucabtagene , Yescarta Axicabtagene , Aleta Biotherapeutics , Astellas Xyphos , Laura Wood , Janssen Biotech Inc , Celgene Corporation , Promab Biotechnologies Inc , Formula Pharmaceuticals Inc , Poseida Therapeutics Inc , Fate Therapeutics Inc , Celularity Inc , Clinical Trial Sponsor Companies , Carisma Therapeutics Inc , Maxcyte Inc , Office Hours Call , Minerva Biotechnologies Corporation , Xyphos Biosciences Inc , Eureka Therapeutics Inc ,